ISHITA DRUGS & INDUSTRIES LTD. Share Price

ISHITA DRUGS & INDUSTRIES LTD. Share Price

BSE: 524400
|
Pharmaceuticals
₹ 74.05
+₹2.09 (2.90%)
1D
Last updated 24 Jul, 2026, 15:26 IST

ISHITA DRUGS & INDUSTRIES LTD. Share Price Today

As of 25 Jul 2026, ISHITA DRUGS & INDUSTRIES LTD. share price is ₹74.05. The stock opened at ₹74.60, compared to its previous close of ₹71.96. During today's trading session, ISHITA DRUGS & INDUSTRIES LTD. share price moved in the range of ₹74.05 to ₹74.60, with an average price of ₹74.32 for the day. Looking at its last 52-week, the stock has touched a low of ₹66.00 and a high of ₹90.85.

₹74.05
2.90% up today
₹74.60
1D LOW
1D HIGH

ISHITA DRUGS & INDUSTRIES LTD. Returns Calculator

Circuit
L
H
₹57.57
₹86.35
52-week
L
H
₹66.00
₹90.85
Mkt Cap Cr
21.52
P/E
27.68
P/B
1.86
ROE
6.73%
D/E
0.01
ROCE
9.78%
Div. Yield
0.00%
EPS(TTM)
2.60
Turnover
1.26
EV/EBITDA
15.01
Net Margin
0.00%
Op. Margin
0.00%
ROA
6.19%
Quick Ratio
0.00
Curr. Ratio
10.14
Based on fundamentals, this stock's
Step 2 of 5
Performance
Poor
Ishita Drugs has underperformed the market
Step 2 of 5
Valuation
Expensive
Ishita Drugs PE is significantly higher than its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,65,711.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,93,860.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,92,687.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,12,593.0033.553.2711.27%0.0014.95%423.360.93%0.4443.52
Zydus Lifesciences1,11,082.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,09,553.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,05,607.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories96,204.7030.222.5311.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma88,508.4025.272.349.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,727.3060.2610.1018.21%0.4016.70%97.210.12%0.6413.72

ISHITA DRUGS & INDUSTRIES LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹15.00₹15.19₹12.07₹14.09
Other Income₹0.34₹0.28₹0.20₹0.11
Total Revenue₹15.33₹15.47₹12.27₹14.20
Total Expenses₹14.18₹14.48₹11.49₹13.15
Profit Before Tax₹1.16₹0.99₹0.78₹1.04
Tax₹0.29₹0.24₹0.20₹0.24
Profit After Tax₹0.87₹0.75₹0.58₹0.80
EPS - Basic₹2.90₹2.50₹1.93₹2.69
EPS - Diluted₹2.90₹2.50₹1.93₹2.69

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹1.16₹0.99₹0.78₹1.04
Income before WC changes₹1.00₹0.91₹0.76₹1.09
Change in Assets-₹4.86₹1.84-₹2.07₹0.77
Change in Liabilities₹0.22-₹0.63-₹1.59₹1.21
Change in WC-₹4.64₹1.21-₹3.66₹1.99
Cash flow from Operations-₹3.64₹2.12-₹2.90₹3.08
Cash flow from Investing-₹0.67₹0.13₹0.59-₹0.93
Cash flow from Financing₹4.33-₹0.87₹1.05₹0.00
Total Cash Flow₹0.02₹1.38-₹1.25₹2.14
Cash (Start of the year)₹4.81₹3.43₹4.68₹2.54
Cash (End of the year)₹4.83₹4.81₹3.43₹4.68

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹1.31₹1.15₹1.23₹1.21
Current Assets₹14.98₹9.66₹10.18₹10.05
Total Assets₹16.30₹10.81₹11.41₹11.25
Current Liabilities₹5.40₹0.87₹2.21₹2.63
Net Current Asset₹9.58₹8.79₹7.96₹7.42
Non-Current Liabilities₹0.10₹0.02₹0.02₹0.03
Equity Capital₹10.79₹9.92₹9.17₹8.60
Total Equity & Liabilities₹16.30₹10.81₹11.41₹11.25
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
45.01
Neutral
ATR (14)
2.77
Neutral
STOCH(9,6)
43.71
Neutral
STOCH RSI (14)
32.78
Neutral
ADX(9)
25.77
Bearish
UO(9)
29.16
Bullish
ROC(12)
-3.29
Bearish
WillR(14)
-60.61
Neutral
Period
Simple value
Exponential vaue
5D
71.67
71.9
10D
72.6
72.43
20D
73.42
73.3
50D
76.13
74.9
100D
75.87
75.2

About ISHITA DRUGS & INDUSTRIES LTD.

ISHITA DRUGS & INDUSTRIES LTD. Share Price
ISIN
INE806D01016
Sector Market Cap
₹ 21.52 Cr

Ishita Drugs and Industries Limited is a manufacturer of various active pharma ingredients (APIs) (bulk actives and their salts), drug intermediates, excipients, and fine chemicals. The Company's APIs include sulpha drugs/sulfonamides, vitamins, fluoroquinolones, antibiotics, anthelmintics, iodides and citrates (salts), food additive/excipients, and others. Its drug intermediates include 4- Sulfonamido Phenyl Hydrazine Hydrochloride (Celecoxib Intermediate), 4- Chloro Phenyl Hydrazine Hydrochloride (intermediate for Indole Carboxylic Acid), L-Alanine Benzylester Tosylate, 5 Cyano Phthalide (Citalopram Intermediate), Indole 2 Carboxylic Acid, Ethyl 3-Benzoyl Acrylate, Hexa Methyl Disilazane, 5-Chloromethopabate, and others. Its fine chemicals include salicylanilide, para bromo toluene, pyridine hydrobromide, potassium phthalimide, nicotinic acid hydrazide, 3 amino pyridine, and methyl iodide. The Company has three manufacturing facilities located in the state of Gujarat.

ISHITA DRUGS & INDUSTRIES LTD. Financial Highlights

  • Revenue: ISHITA DRUGS & INDUSTRIES LTD. reported revenue of ₹15.13 crore in FY26 vs ₹15.34 crore in FY25. It showed a decrease of 1.37% on a yearly basis.
  • Operating Profit: ISHITA DRUGS & INDUSTRIES LTD. reported an operating profit of ₹1.08 crore in FY26 vs ₹1.16 crore in FY25. It showed a decrease of 6.90% on a year-on-year basis.
  • Net Profit: ISHITA DRUGS & INDUSTRIES LTD. reported a net profit of ₹0.78 crore in FY26 vs ₹0.87 crore in FY25. It showed a decrease of 10.34% on a yearly basis.

ISHITA DRUGS & INDUSTRIES LTD. Quarterly Result Highlights

  • ISHITA DRUGS & INDUSTRIES LTD. reported revenue of ₹3.28 crore in Mar 2026, compared with ₹3.24 crore in Dec 2025, representing an increase of 1.23% on a quarter-on-quarter (QoQ) basis.
  • ISHITA DRUGS & INDUSTRIES LTD. reported an operating profit of ₹0.28 crore in Mar 2026, compared with ₹0.19 crore in Dec 2025, representing an increase of 47.37% on a quarter-on-quarter (QoQ) basis.
  • ISHITA DRUGS & INDUSTRIES LTD. reported a profit of ₹0.18 crore in Mar 2026, compared with ₹0.16 crore in Dec 2025, reflecting an increase of 12.50% on a QoQ basis.
  • The earnings per share (EPS) of ISHITA DRUGS & INDUSTRIES LTD. stood at ₹2.90 during Mar 2026.
Know more
Promoters
50.04%
FII
0.00%
Other DII
0.00%
Retail and other
49.96%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
ISHITA DRUGS & INDUSTRIES LTD. Share Price
ISHITA DRUGS & INDUSTRIES LTD.
Pharmaceuticals
Add Stock
Add Another

FAQs on ISHITA DRUGS & INDUSTRIES LTD. Share Price